UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.
Three UC Davis Health residency programs have been awarded $950,000 by CalMedForce. The grant program helps address California’s physician shortage by supporting residency programs.
A new study by UC Davis MIND Institute researchers finds that changes in the IQ level of autistic youth may help predict their developmental path as adolescents.
The UCI Health Gavin Herbert Eye Institute now offers sight-saving ocular stem cell transplants for severe eye surface damage, becoming only the second medical institution in the nation to treat this blinding condition. UCI Health cornea specialist Dr. Marjan Farid, who leads the UCI Health Severe Ocular Surface Disease Program…
The new UC San Diego Shiley EyeMobile for Children has started its engine and is driving to schools in San Diego County to serve low-income families in need of eye exams.
Three UCSF researchers were named 2022 fellows by the American Association for the Advancement of Science (AAAS), one of the highest honors in science.
The Regents of the University of California met at UC Riverside on Friday, Jan. 27, in a daylong series of meetings that highlighted the campus’s role in spurring economic growth through technology development, agricultural innovation, and public health.
Health Media Contacts
Find the best contact for health-related media inquiries.
